FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stacy Loeb

Research Profile

Disorders

Prostatic Neoplasms

Chemicals & Drugs

Prostate Specific Antigen

Procedures

Concepts & Ideas

Anatomy

Prostate

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Stacy Loeb
Prostate Health Index (PHI): Golden Bullet or Just Another Prostate Cancer Marker?
Stacy Loeb; Leonard S Marks; IA Mizrahi; Alan W Partin; William L Roberts; Martin G Sanda; Sanghyuk S Shin; Kevin M Slawin; Lori J Sokoll; Ron H N van Schaik; John T Wei; Chris H Bangma; Dennis L Broyles; Daniel W Chan; Amabelle B Cruz; George G Klee; William J Catalona
Prospective Multicenter Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration.
Stacy Loeb; H Ballentine Carter
Point: Impact of prostate-specific antigen velocity on management decisions and recommendations.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stacy Loeb (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stacy Loeb
Prostate Health Index (PHI): Golden Bullet or Just Another Prostate Cancer Marker?
European urology 2013;63(6):995-6.
2013: Stacy Loeb; Leonard S Marks; IA Mizrahi; Alan W Partin; William L Roberts; Martin G Sanda; Sanghyuk S Shin; Kevin M Slawin; Lori J Sokoll; Ron H N van Schaik; John T Wei; Chris H Bangma; Dennis L Broyles; Daniel W Chan; Amabelle B Cruz; George G Klee; William J Catalona
Prospective Multicenter Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration.
The Journal of urology 2013;189(5):1702-6.
2013: Stacy Loeb; H Ballentine Carter
Point: Impact of prostate-specific antigen velocity on management decisions and recommendations.
Journal of the National Comprehensive Cancer Network : JNCCN 2013;11(3):281-5.
2013: Stacy Loeb; Winnie Ricker; Sonja I Berndt; H Ballentine Carter; Edward M Schaeffer
Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.
The Journal of urology 2013;189(3):867-70.
2013: Stacy Loeb; David Robinson; Sigrid Carlsson; Linda Drevin; Erik Holmberg; Mats Lambe; Pär Stattin
Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study.
Cancer causes & control : CCC 2013;24(2):383-90.
2013: Annelies Vellekoop; Stacy Loeb
Update of randomized trials for prostate cancer screening.
Reviews in urology 2013;15(1):37-9.
2013: Stacy Loeb; Lia Losonczy; Jeffrey Tosoian; Angela Gupta; Patrick C Walsh
Does benign prostatic hyperplasia treatment with alpha-blockers affect prostate cancer risk?
Current opinion in urology 2013;23(1):2-4.
2012: Jeffrey K Mullins; Bruce J Trock; Patrick C Walsh; Jonathan I Epstein; Zhaoyong Feng; Stacy Loeb
The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary.
The Journal of urology 2012;188(6):2219-24.
2012: Stacy Loeb; Fritz H Schroder; Xiaoye Zhu; Monique J Roobol
Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.
BJU international 2012;110(11):1678-83.
2012: Jeffrey J Tosoian; Bruce J Trock; Robert W Veltri; H Ballentine Carter; Debra J Elliot; Jonathan I Epstein; Zhaoyong Feng; Sumit Isharwal; Patricia Landis; Stacy Loeb; Alan W Partin; Lori J Sokoll
Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer.
The Journal of urology 2012;188(4):1131-6.
2012: Stacy Loeb; Gustavo F Carvalhal; Angel Desai; Donghui Kan; William J Catalona
External validation of the cancer of the prostate risk assessment (CAPRA) score in a single-surgeon radical prostatectomy series.
Urologic oncology 2012;30(5):584-9.
2012: Stacy Loeb; Michelle Jo Semins; Brian R Matlaga
Novel technique for fragment removal after percutaneous management of large-volume neobladder calculi.
Urology 2012;80(2):474-6.
2012: Stacy Loeb
An examination of the dynamic changes in prostate-specific antigen occurring in a population-based cohort of men over time.
BJU international 2012;110(3):381-2.
2012: Stacy Loeb; Fritz H Schröder; Suzanne van den Heuvel; Xiaoye Zhu; Chris H Bangma; Monique J Roobol
Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.
European urology 2012;61(6):1110-4.
2012: Stacy Loeb
Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use.
BJU international 2012;109(12):1785-6.
2012: Barry B McGuire; Daniel O'Brien; Ximing Yang; Phillip Cooper; Brian T Helfand; Qiaoyan Hu; Stacy Loeb; William J Catalona
Outcomes in patients with Gleason score 8-10 prostate cancer: relation to preoperative PSA level.
BJU international 2012;109(12):1764-9.
2012: Stacy Loeb
Use of baseline prostate-specific antigen measurements to personalize prostate cancer screening.
European urology 2012;61(5):875-6; discussion 876-7.
2012: Stacy Loeb; Sigrid Carlsson; R Scott Braithwaite
Prostate cancer: modeling the outcomes of prostate cancer screening.
Nature reviews. Urology 2012;9(4):183-5.
2012: Stacy Loeb
Editorial comment.
Urology 2012;79(3):661.
2012: Jeffrey K Mullins; Stacy Loeb
Environmental exposures and prostate cancer.
Urologic oncology 2012;30(2):216-9.
2012: Stacy Loeb; E Jeffrey Metter; Kimberly A Roehl; Donghui Kan; William J Catalona
Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer.
BJU international 2012;109(4):508-13; discussion 513-4.
2012: Stacy Loeb; James F Borin
Innovation in Endourology and Minimally Invasive Surgery: Highlights From the 29th World Congress of Endourology and SWL 2011, November 30-December 3, 2011, Kyoto, Japan.
Reviews in urology 2012;14(1-2):28-30.
2012: Jeffrey J Tosoian; Stacy Loeb
Radical retropubic prostatectomy: comparison of the open and robotic approaches for treatment of prostate cancer.
Reviews in urology 2012;14(1-2):20-7.
2012: Stacy Loeb; Judd W Moul; H Ballentine Carter; William J Catalona; Fritz H Schroder
Baseline prostate-specific antigen testing at a young age.
European urology 2012;61(1):1-7.
2011: Stacy Loeb; Bruce J Trock
Re: randomised prostate cancer screening trial: 20 year follow-up.
European urology 2011;60(6):1306-7.
2011: Angela D Gupta; Stacy Loeb; Andrew A J Stec; Ming-Hsien Wang
Unusual presentation of a Mullerian remnant in an infant with recurrent epididymo-orchitis.
Urology 2011;78(6):1414-6.
2011: Stacy Loeb; Winnie Ricker; Sonja I Berndt; H Ballentine Carter; Edward M Schaeffer
Complications after prostate biopsy: data from SEER-Medicare.
The Journal of urology 2011;186(5):1830-4.
2011: Stacy Loeb
Editorial comment.
Urology 2011;78(4):879-80.
2011: Phillip R Cooper; Brian T Helfand; Qiaoyan Hu; Stacy Loeb; Barry B McGuire; William J Catalona
Prostate cancer risk alleles and their associations with other malignancies.
Urology 2011;78(4):970.e15-20.
2011: Stacy Loeb
Editorial comment.
Urology 2011;78(2):255-6; authro reply 256.
2011: Stacy Loeb
Editorial comment.
Urology 2011;78(2):248-9; author reply 249.
2011: Stacy Loeb; Ashley Ross; Bruce J Trock; Zhaoyong Feng; Elizabeth B Humphreys; Patrick C Walsh
Can we stop prostate specific antigen testing 10 years after radical prostatectomy?
The Journal of urology 2011;186(2):500-5.
2011: Stacy Loeb
Prediction of outcomes after radical prostatectomy in patients diagnosed with prostate cancer of biopsy Gleason score ≥ 8 via contemporary multi(≥ 12)-core prostate biopsy.
BJU international 2011;108(2):222.
2011: Stacy Loeb
Use of empiric antibiotics in the setting of an increased prostate specific antigen: pro.
The Journal of urology 2011;186(1):17-9.
2011: Daniel O'Brien; Stacy Loeb; Gustavo F Carvalhal; Barry B McGuire; Donghui Kan; Matthias D Hofer; Jessica T Casey; Brian T Helfand; William J Catalona
Delay of surgery in men with low risk prostate cancer.
The Journal of urology 2011;185(6):2143-7.
2011: William J Catalona; Alan W Partin; Martin G Sanda; John T Wei; George G Klee; Chris H Bangma; Kevin M Slawin; Leonard S Marks; Stacy Loeb; Dennis L Broyles; Sanghyuk S Shin; Amabelle B Cruz; Daniel W Chan; Lori J Sokoll; William L Roberts; Ron H N van Schaik; Isaac A Mizrahi
A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.
The Journal of urology 2011;185(5):1650-5.
2011: Stacy Loeb
Germline sequence variants and prostate-specific antigen interpretation.
Clinical chemistry 2011;57(5):662-3.
2011: Stacy Loeb; Edward F Vonesh; E Jeffrey Metter; H Ballentine Carter; Peter H Gann; William J Catalona
What is the true number needed to screen and treat to save a life with prostate-specific antigen testing?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(4):464-7.
2011: Danil V Makarov; Stacy Loeb; Ahmed Magheli; Kevin Zhao; Elizabeth Humphreys; Mark L Gonzalgo; Alan W Partin; Misop Han
Significance of preoperative PSA velocity in men with low serum PSA and normal DRE.
World journal of urology 2011;29(1):11-4.
2011: Stacy Loeb; Alan W Partin
Imaging utilization for the staging of clinically localized prostate cancer.
Reviews in urology 2011;13(1):63-4.
2011: Stacy Loeb; H Ballentine Carter; Edward M Schaeffer; Anna Kettermann; Luigi Ferrucci; E Jeffrey Metter
Distribution of PSA velocity by total PSA levels: data from the Baltimore Longitudinal Study of Aging.
Urology 2011;77(1):143-7.
2010: Brian T Helfand; Stacy Loeb; Donghui Kan; William J Catalona
Number of prostate cancer risk alleles may identify possibly 'insignificant' disease.
BJU international 2010;106(11):1602-6.
2010: Gustavo F Carvalhal; Saima N Daudi; Donghui Kan; Dana Mondo; Kimberly A Roehl; Stacy Loeb; William J Catalona
Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes.
Urology 2010;76(5):1072-6.
2010: Stacy Loeb; Edward M Schaeffer; Jonathan I Epstein
The vanishing prostate cancer phenomenon.
Urology 2010;76(3):605-7.
2010: Stacy Loeb; Edward M Schaeffer; Bruce J Trock; Jonathan I Epstein; Elizabeth B Humphreys; Patrick C Walsh
What are the outcomes of radical prostatectomy for high-risk prostate cancer?
Urology 2010;76(3):710-4.
2010: Brian T Helfand; Angela J Fought; Stacy Loeb; Joshua J Meeks; Donghui Kan; William J Catalona
Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.
The Journal of urology 2010;184(2):501-5.
2010: Stacy Loeb; Danil V Makarov; Edward M Schaeffer; Elizabeth B Humphreys; Patrick C Walsh
Prostate specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomy.
The Journal of urology 2010;184(1):157-61.
2010: Stacy Loeb; H Ballentine Carter; Edward M Schaeffer; Shari Miura Ling; Anna Kettermann; Luigi Ferrucci; E Jeffrey Metter
Bone mineral content and prostate cancer risk: data from the Baltimore Longitudinal Study of Aging.
BJU international 2010;106(1):28-31.
2010: Ashley E Ross; Stacy Loeb; Patricia Landis; Alan W Partin; Jonathan I Epstein; Anna Kettermann; Zhaoyong Feng; H Ballentine Carter; Patrick C Walsh
Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(17):2810-6.
2010: Gustavo F Carvalhal; Christopher R Griffin; Donghui Kan; Stacy Loeb; William J Catalona
Reducing blood loss in open radical retropubic prostatectomy with prophylactic periprostatic sutures.
BJU international 2010;105(12):1650-3.
2010: Stacy Loeb; Jonathan I Epstein; Elizabeth B Humphreys; Patrick C Walsh
Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes?
BJU international 2010;105(11):1510-3.
2010: Stacy Loeb; Jonathan I Epstein; Ashley E Ross; Luciana Schultz; Elizabeth B Humphreys; Jonathan P Jarow
Benign prostate glands at the bladder neck margin in robotic vs open radical prostatectomy.
BJU international 2010;105(10):1446-9.
2010: Stacy Loeb; Donghui Kan; Xiaoying Yu; Kimberly A Roehl; William J Catalona
Preoperative prostate specific antigen doubling time is not a useful predictor of biochemical progression after radical prostatectomy.
The Journal of urology 2010;183(5):1816-21.
2010: Stacy Loeb; William J Catalona
Prostate-specific antigen screening: pro.
Current opinion in urology 2010;20(3):185-8.
2010: Stacy Loeb; Donghui Kan; Brian T Helfand; Robert B Nadler; William J Catalona
Is statin use associated with prostate cancer aggressiveness?
BJU international 2010;105(9):1222-5.
2010: Stacy Loeb; William J Catalona
Prostate cancer: utility of the risk indicator model in screening.
Nature reviews. Urology 2010;7(4):184-5.
2010: Brian V Le; Christopher R Griffin; Stacy Loeb; Gustavo F Carvalhal; Donghui Kan; Nikola A. Baumann; William J Catalona
[-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study.
The Journal of urology 2010;183(4):1355-9.
2010: Edward M Schaeffer; Stacy Loeb; Patrick C Walsh
The case for open radical prostatectomy.
The Urologic clinics of North America 2010;37(1):49-55, Table of Contents.
2010: William J Catalona; Stacy Loeb
Prostate cancer screening and determining the appropriate prostate-specific antigen cutoff values.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(2):265-70.
2010: Jeffrey J Tosoian; Stacy Loeb; Anna Kettermann; Patricia Landis; Debra J Elliot; Jonathan I Epstein; Alan W Partin; H Ballentine Carter; Lori J Sokoll
Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program.
The Journal of urology 2010;183(2):534-8.
2010: C Shad Thaxton; Stacy Loeb; Kimberly A Roehl; Donghui Kan; William J Catalona
Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols.
Urology 2010;75(2):414-8.
2010: Stacy Loeb; Alan W Partin
PCA3 Urinary Biomarker for Prostate Cancer.
Reviews in urology 2010;12(4):e205-6.
2010: Trinity J Bivalacqua; Stacy Loeb; Phillip M Pierorazio; Mark P Schoenberg; Alan W Partin; THOMAS GUZZO
Is prostate-specific antigen surveillance necessary in men with benign prostate pathology following radical cystoprostatectomy for bladder cancer?
Urologia internationalis 2010;85(4):466-9.
2010: Stacy Loeb; Alan W Partin
What is the true mortality benefit of prostate-specific antigen screening?
Reviews in urology 2010;12(1):66-7.
2010: Stacy Loeb; Alan W Partin
Open versus minimally invasive radical prostatectomy.
Reviews in urology 2010;12(1):64-5.
2010: Stacy Loeb; Alan W Partin; Edward M Schaeffer
Complications of pelvic lymphadenectomy: do the risks outweigh the benefits?
Reviews in urology 2010;12(1):20-4.
2010: Stacy Loeb; Kimberly A Roehl; Brian T Helfand; Donghui Kan; William J Catalona
Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection?
The Journal of urology 2010;183(1):112-6.
2009: Stacy Loeb; H Ballentine Carter; Edward M Schaeffer; Luigi Ferrucci; Anna Kettermann; E Jeffrey Metter
Should prostate specific antigen be adjusted for body mass index? Data from the Baltimore Longitudinal Study of Aging.
The Journal of urology 2009;182(6):2646-51.
2009: Stacy Loeb
Editorial comment.
The Journal of urology 2009;182(6):2701.
2009: Stacy Loeb; Brian T Helfand; Donghui Kan; William B Isaacs; William J Catalona
Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?
BJU international 2009;104(9):1200-3.
2009: Stacy Loeb; Anna Kettermann; H Ballentine Carter; Luigi Ferrucci; E Jeffrey Metter; Patrick C Walsh
Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging.
The Journal of urology 2009;182(4):1458-62.
2009: Bruce J Trock; Charles C Guo; Mark L Gonzalgo; Ahmed Magheli; Stacy Loeb; Jonathan I Epstein
Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system.
The Journal of urology 2009;182(4):1364-70.
2009: Stacy Loeb; Edward M Schaeffer
Optimal therapy in localized prostate cancer: an unfolding story.
Oncology (Williston Park, N.Y.) 2009;23(10):843, 846.
2009: Stacy Loeb; Edward M Schaeffer
Risk factors, prevention and early detection of prostate cancer.
Primary care 2009;36(3):603-21.
2009: Brian T Helfand; Anne K Mongiu; Donghui Kan; Dae-Yun Kim; Stacy Loeb; Kimberly A Roehl; Joshua J Meeks; Norm D Smith; William J Catalona
Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease.
BJU international 2009;104(3):304-9.
2009: Stacy Loeb; H Ballentine Carter; Patrick C Walsh; William B Isaacs; Anna Kettermann; Toshiko Tanaka; Luigi Ferrucci; E Jeffrey Metter
Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level.
The Journal of urology 2009;182(1):101-4; discussion 105.
2009: Brian T Helfand; Stacy Loeb; Joshua J Meeks; Angela J Fought; Donghui Kan; William J Catalona
Pathological outcomes associated with the 17q prostate cancer risk variants.
The Journal of urology 2009;181(6):2502-7.
2009: Joshua J Meeks; Stacy Loeb; Brian T Helfand; Donghui Kan; Norm D Smith; William J Catalona
Characteristics of prostate cancers detected at prostate specific antigen levels less than 2.5 ng/ml.
The Journal of urology 2009;181(6):2515-8; discussion 2518-9.
2009: Stacy Loeb; Edward M Schaeffer; Daniel W Chan; H Ballentine Carter; Patrick C Walsh; Lori J Sokoll
Investigation of human anti-mouse antibodies as potential cause of postprostatectomy PSA elevation.
Urology 2009;73(5):947-9.
2009: Stacy Loeb; H Ballentine Carter
Words of wisdom. Re: Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
European urology 2009;55(2):523-4.
2009: Stacy Loeb; William J Catalona
What is the role of digital rectal examination in men undergoing serial screening of serum PSA levels?
Nature clinical practice. Urology 2009;6(2):68-9.
2009: Stacy Loeb; Alan W Partin
Randomized trials of prostate cancer screening.
Reviews in urology 2009;11(3):179-80.
2009: Stacy Loeb; Alan W Partin
Randomized trials of selenium, vitamin e, or vitamin C for prostate cancer prevention.
Reviews in urology 2009;11(2):114-5.
2009: Stacy Loeb; Sara N Gashti; William J Catalona
Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA).
Urologic oncology 2009;27(1):64-6.
2009: Stacy Loeb; Tamara LEVIN Lotan; KATHERINE THORNTON; Susan L Gearhart; Mark P Schoenberg
A case of gastrointestinal stromal tumor diagnosed on prostate biopsy.
Nature clinical practice. Urology 2009;6(1):54-7.
2009: Danil V Makarov; Stacy Loeb; Robert H Getzenberg; Alan W Partin
Biomarkers for prostate cancer.
Annual review of medicine 2009;60():139-51.
2008: Stacy Loeb; Daniel W Chan; Lori J Sokoll; Donghui Kan; Jack Maggiore; Stephen D Mikolajczyk; Dana M Mondo; Chris R Griffin; William J Catalona
Prostate specific antigen assay standardization bias could affect clinical decision making.
The Journal of urology 2008;180(5):1959-62; discussion 1962-3.
2008: Stacy Loeb
Does PCA3 help identify clinically significant prostate cancer?
European urology 2008;54(5):980-1.
2008: Amanda M Macejko; Joseph F Pazona; Stacy Loeb; Simon Y Kimm; Robert B Nadler
Management of distal ureter in laparoscopic nephroureterectomy--a comprehensive review of techniques.
Urology 2008;72(5):974-81.
2008: Stacy Loeb; Kimberly A Roehl; C Shad Thaxton; William J Catalona
Combined prostate-specific antigen density and biopsy features to predict "clinically insignificant" prostate cancer.
Urology 2008;72(1):143-7.
2008: Brian T Helfand; Stacy Loeb; John Cashy; Joshua J Meeks; C Shad Thaxton; Misop Han; William J Catalona
Tumor characteristics of carriers and noncarriers of the deCODE 8q24 prostate cancer susceptibility alleles.
The Journal of urology 2008;179(6):2197-201; discussion 2202.
2008: Scott E Eggener; Ofer Yossepowitch; Kimberly A Roehl; Stacy Loeb; Xiaoying Yu; William J Catalona
Relationship of prostate-specific antigen velocity to histologic findings in a prostate cancer screening program.
Urology 2008;71(6):1016-9.
2008: Lee C Zhao; Justin S Han; Stacy Loeb; Chris Tenggardjaja; Ronald A Rubenstein; Norm D Smith; Robert B Nadler
Thoracic complications of urologic laparoscopy: correlation between radiographic findings and clinical manifestations.
Journal of endourology / Endourological Society 2008;22(4):607-14.
2008: Joshua J Meeks; C Shad Thaxton; Stacy Loeb; Kimberly A Roehl; Brian T Helfand; William J Catalona
Comparison of prostate specific antigen velocity in screened versus referred patients with prostate cancer.
The Journal of urology 2008;179(4):1340-3.
2008: Stacy Loeb; Alan W Partin
Single nucleotide polymorphisms and prostate cancer susceptibility.
Reviews in urology 2008;10(4):304-5.
2007: Onisuru T Okotie; Kimberly A Roehl; Misop Han; Stacy Loeb; Sara N Gashti; William J Catalona
Characteristics of prostate cancer detected by digital rectal examination only.
Urology 2007;70(6):1117-20.
2007: Naresh V Desireddi; Kimberly A Roehl; Stacy Loeb; Xiaoying Yu; Christopher R Griffin; Shilajit K Kundu; Misop Han; William J Catalona
Improved stage and grade-specific progression-free survival rates after radical prostatectomy in the PSA era.
Urology 2007;70(5):950-5.
2007: Stacy Loeb; William J Catalona
Open radical retropubic prostatectomy.
Urologic oncology 2007;25(6):494-8.
2007: Ronald A Rubenstein; Lee C Zhao; Stacy Loeb; David M Shore; Robert B Nadler
Prestenting improves ureteroscopic stone-free rates.
Journal of endourology / Endourological Society 2007;21(11):1277-80.
2007: Christopher R Griffin; Xiaoying Yu; Stacy Loeb; Vic N Desireddi; Misop Han; Theresa Graif; William J Catalona
Pathological features after radical prostatectomy in potential candidates for active monitoring.
The Journal of urology 2007;178(3 Pt 1):860-3; discussion 863.
2007: Stacy Loeb; William J Catalona
Counterpoint: the case for immediate active treatment.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(7):699-702.
2007: Stacy Loeb; William J Catalona
Early versus delayed intervention for prostate cancer: the case for early intervention.
Nature clinical practice. Urology 2007;4(7):348-9.
2007: Theresa Graif; Stacy Loeb; Kimberly A Roehl; Sara N Gashti; Christopher Griffin; Xiaoying Yu; William J Catalona
Under diagnosis and over diagnosis of prostate cancer.
The Journal of urology 2007;178(1):88-92.
2007: Stacy Loeb; Norm D Smith; Kimberly A Roehl; William J Catalona
Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer.
Urology 2007;69(6):1170-5.
2007: Stacy Loeb; Robert B Nadler; Kimberly A Roehl; Jo Ann V Antenor; William J Catalona
Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
The Journal of urology 2007;177(5):1745-8.
2007: John H Lynch; Stacy Loeb
The role of high-intensity focused ultrasound in prostate cancer.
Current oncology reports 2007;9(3):222-5.
2007: Stacy Loeb; William J Catalona
Prostate-specific antigen in clinical practice.
Cancer letters 2007;249(1):30-9.
2007: Xiaoying Yu; Stacy Loeb; Kimberly A Roehl; Misop Han; William J Catalona
The association between total prostate specific antigen concentration and prostate specific antigen velocity.
The Journal of urology 2007;177(4):1298-302; discussion 1301-2.
2007: Stacy Loeb; Kimberly A Roehl; William J Catalona; Robert B Nadler
Prostate specific antigen velocity threshold for predicting prostate cancer in young men.
The Journal of urology 2007;177(3):899-902.
2007: Scott E Eggener; Brett S Carver; Stacy Loeb; G Varuni Kondagunta; George J Bosl; Joel Sheinfeld
Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
Cancer 2007;109(3):528-35.
2007: Stacy Loeb; Kimberly A Roehl; Xiaoying Yu; Misop Han; William J Catalona
Use of prostate-specific antigen velocity to follow up patients with isolated high-grade prostatic intraepithelial neoplasia on prostate biopsy.
Urology 2007;69(1):108-12.
2007: Stacy Loeb; Xiaoying Yu; Robert B Nadler; Kimberly A Roehl; Misop Han; Sheila A Hawkins; William J Catalona
Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?
The Journal of urology 2007;177(1):102-6; discussion 106.
2006: Kimberly A Roehl; Stacy Loeb; Jo Ann V Antenor; Nicol Corbin; William J Catalona
Characteristics of patients with familial versus sporadic prostate cancer.
The Journal of urology 2006;176(6 Pt 1):2438-42; discussion 2442.
2006: Xiaoying Yu; Misop Han; Stacy Loeb; Sara N Gashti; Joannie T Yeh; Kimberly A Roehl; William J Catalona
Comparison of methods for calculating prostate specific antigen velocity.
The Journal of urology 2006;176(6 Pt 1):2427-31; discussion 2431.
2006: Kimberly A Roehl; Scott E Eggener; Stacy Loeb; Norm D Smith; Jo Ann V Antenor; William J Catalona
Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results.
Urologic oncology 2006;24(6):465-71.
2006: Robert B Nadler; Stacy Loeb; Ronald A Rubenstein; Itay Y Vardi
Use of BioGlue in laparoscopic partial nephrectomy.
Urology 2006;68(2):416-8.
2006: Stacy Loeb; William J Catalona
What is the prognostic impact of positive surgical margins in surgically treated prostate cancer?
Nature clinical practice. Urology 2006;3(8):418-9.
2006: Stacy Loeb; Kimberly A Roehl; Xiaoying Yu; Jo Ann V Antenor; Misop Han; Sara N Gashti; Ximing J Yang; William J Catalona
Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression.
Urology 2006;68(1):99-103.
2006: William J Catalona; Stacy Loeb
Making prostate-specific antigen testing more effective.
Urologic oncology 2006;24(3):177-9.
2006: Robert B Nadler; Stacy Loeb; J Quentin Clemens; Robert A Batler; Chris M Gonzalez; Itay Y Vardi
A prospective study of laparoscopic radical nephrectomy for T1 tumors--is transperitoneal, retroperitoneal or hand assisted the best approach?
The Journal of urology 2006;175(4):1230-3; discussion 1234.
2006: Stacy Loeb; Chris M Gonzalez; Kimberly A Roehl; Misop Han; Jo Ann V Antenor; Ronald L Yap; William J Catalona
Pathological characteristics of prostate cancer detected through prostate specific antigen based screening.
The Journal of urology 2006;175(3 Pt 1):902-6.
2006: Stacy Loeb; Kimberly A Roehl; Jo Ann V Antenor; William J Catalona; Brian K Suarez; Robert B Nadler
Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.
Urology 2006;67(2):316-20.
2005: Robert B Nadler; Stacy Loeb; Kimberly A Roehl; Jo Ann V Antenor; Scott E Eggener; William J Catalona
Use of 2.6 ng/ml prostate specific antigen prompt for biopsy in men older than 60 years.
The Journal of urology 2005;174(6):2154-7, discussion 2157.
2005: Stacy Loeb; Misop Han; Kimberly A Roehl; Jo Ann V Antenor; William J Catalona
Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography.
The Journal of urology 2005;173(1):63-5.